Your browser doesn't support javascript.
loading
A double-blind, randomized, placebo- and positive-controlled phase III trial of 1% benvitimod cream in mild-to-moderate plaque psoriasis.
Cai, Lin; Chen, Gen-Hui; Lu, Qian-Jin; Zheng, Min; Li, Yu-Zhen; Chen, Jin; Zheng, Jie; Zhang, Fu-Ren; Yu, Jian-Bin; Yang, Sen; Li, Fu-Qiu; Xiao, Sheng-Xiang; Sun, Qiu-Ning; Xu, Jin-Hua; Gao, Xing-Hua; Fang, Hong; Gao, Tian-Wen; Hao, Fei; Liu, Quan-Zhong; Tu, Ya-Ting; Li, Ruo-Yu; Wang, Bao-Xi; Deng, Dan-Qi; Zheng, Qing-Shan; Liu, Hong-Xia; Zhang, Jian-Zhong.
Afiliação
  • Cai L; Department of Dermatology, Peking University People's Hospital, Beijing 100044, China.
  • Chen GH; Beijing Wenfeng Tianji Pharma Ltd., Beijing 100044, China.
  • Lu QJ; Department of Dermatology, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China.
  • Zheng M; Department of Dermatology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009, China.
  • Li YZ; Department of Dermatology, Harbin Medical University Second Hospital, Harbin, Heilongjiang 150001, China.
  • Chen J; Department of Dermatology, Sichuan Provincial People's Hospital, Chengdu, Sichuan 610072, China.
  • Zheng J; Department of Dermatology, Shanghai JiaoTong University School of Medicine Ruijin Hospital, Shanghai 213002, China.
  • Zhang FR; Shandong Provinical Institute of Dermatology and Venereology, Jinan, Shandong 250022, China.
  • Yu JB; Department of Dermatology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan 450052, China.
  • Yang S; Department of Dermatology, The First Affiliated Hospital, Anhui Medical University, Hefei, Anhui 230022, China.
  • Li FQ; Department of Dermatology, The Second Hospital of Jilin University, Changchun, Jilin 130041, China.
  • Xiao SX; Department of Dermatology, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi 710004, China.
  • Sun QN; Department of Dermatology, Peking Union Medical College Hospital, Beijing 100730, China.
  • Xu JH; Department of Dermatology, Fudan University Huashan Hospital, Shanghai 200041, China.
  • Gao XH; Department of Dermatology, The First Hospital of China Medical University, Shenyang, Liaoning 110001, China.
  • Fang H; Department of Dermatology, The First Affiliated Hospital, Zhejiang University, Hangzhou, Zhejiang 310006, China.
  • Gao TW; Department of Dermatology, Xijing Hospital, Air Force Medical University of People's Liberation Army, Xi'an, Shaanxi 710032, China.
  • Hao F; Department of Dermatology, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing 400038, China.
  • Liu QZ; Department of Dermatology, Tianjin Medical University General Hospital, Tianjin 300052, China.
  • Tu YT; Department of Dermatology, Wuhan Union Hospital, Wuhan, Hubei 430022, China.
  • Li RY; Department of Dermatology, Peking University First Hospital, Beijing 100034, China.
  • Wang BX; Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, Jiangsu 210042, China.
  • Deng DQ; Department of Dermatology, The Second Affiliated Hospital, Kunming Medical University, Kunming, Yunnan 650101, China.
  • Zheng QS; Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
  • Liu HX; Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
  • Zhang JZ; Department of Dermatology, Peking University People's Hospital, Beijing 100044, China.
Chin Med J (Engl) ; 133(24): 2905-2909, 2020 Nov 09.
Article em En | MEDLINE | ID: mdl-33177393

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Psoríase Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Psoríase Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article